Document Detail


Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis.
MedLine Citation:
PMID:  20024554     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
We investigated the effects of anti-IL-6 receptor antibody, tocilizumab (TCZ), on lipid metabolism. Nineteen patients with rheumatoid arthritis (RA), entered in clinical case-control study of SAMURAI trial at Sasebo Chuo Hospital, were examined. Nine patients received TCZ monotherapy at 8 mg/kg intravenously every 4 weeks (TCZ group) and 10 patients received conventional DMARDs (control group). Serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), apolipoprotein (Apo) A-1, Apo A-2 and Apo B as well as disease activity score (DAS), C-reactive protein and serum amyloid A protein were examined at baseline and after 3 months of the treatment. IL-6 inversely was correlated with LDL, Apo A-1 and Apo A-2, and also tended to correlate with Apo B. In TCZ group, serum levels of TC, HDL, LDL, Apo A-1 and Apo A-2 were significantly increased after 3 months treatment with TCZ. There was no significant change in Apo B, the atherogenic index, and TC/HDL by the TCZ treatment. Changes in the DAS28-ESR negatively correlated with those in TC. In one patient, whose serum level of TCZ was not detected after 3 months of the treatment, the absence of the increment in serum levels of Apo A-1 and A-2 in the patient was remarkable. All of the markers did not change during 3 months in control group. These data may raise an important issue to evaluate the impact of these alternations in lipid metabolism for longer periods in RA patients treated with TCZ.
Authors:
Shin-Ya Kawashiri; Atsushi Kawakami; Satoshi Yamasaki; Takahiro Imazato; Naoki Iwamoto; Keita Fujikawa; Toshiyuki Aramaki; Mami Tamai; Hideki Nakamura; Hiroaki Ida; Tomoki Origuchi; Yukitaka Ueki; Katsumi Eguchi
Related Documents :
7325424 - Evaluation of a new precipitation procedure for estimating high density lipoprotein cho...
2397594 - Distribution of hdl2 and hdl3 in a random population of healthy french males and female...
9814464 - Long-term prospective study of body composition and lipid profiles during and after gro...
12810154 - Polymorphisms in cyp-7a1, not apoe, influence the change in plasma lipids in response t...
7325424 - Evaluation of a new precipitation procedure for estimating high density lipoprotein cho...
19423514 - The association between diet and serum concentrations of igf-i, igfbp-1, igfbp-2, and i...
Publication Detail:
Type:  Journal Article     Date:  2009-12-19
Journal Detail:
Title:  Rheumatology international     Volume:  31     ISSN:  1437-160X     ISO Abbreviation:  Rheumatol. Int.     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-03-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8206885     Medline TA:  Rheumatol Int     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  451-6     Citation Subset:  IM    
Affiliation:
Unit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan, shinya22@nagasaki-u.ac.jp.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Primary central nervous system vasculitis: clinical experiences with 21 new European cases.
Next Document:  Serum chemokines in patients with rheumatoid arthritis treated with etanercept.